Hepatology Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
DCTH | B | Delcath Systems, Inc. | 2.28 | |
MIRM | B | Mirum Pharmaceuticals, Inc. | -0.48 |
Related Industries: Biotechnology Conglomerates Medical Devices
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
HRTS | F | Tema Cardiovascular and Metabolic ETF | 2.6 | |
BBP | C | BioShares Biotechnology Products Fund | 2.41 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 1.47 | |
ILDR | A | First Trust Innovation Leaders ETF | 0.67 | |
FYC | A | First Trust Small Cap Growth AlphaDEX Fund | 0.57 |
Compare ETFs
- Hepatology
Hepatology is the branch of medicine that incorporates the study of liver, gallbladder, biliary tree, and pancreas as well as management of their disorders. Although traditionally considered a sub-specialty of gastroenterology, rapid expansion has led in some countries to doctors specializing solely on this area, who are called hepatologists.
Diseases and complications related to viral hepatitis and alcohol are the main reason for seeking specialist advice. More than two billion people have been infected with hepatitis B virus at some point in their life, and approximately 350 million have become persistent carriers. Up to 80% of liver cancers can be attributed to either hepatitis B or hepatitis C virus. In terms of mortality, the former is second only to smoking among known agents causing cancer. With more widespread implementation of vaccination and strict screening before blood transfusion, lower infection rates are expected in the future. In many countries however, overall alcohol consumption is increasing, and consequently the number of people with cirrhosis and other related complications is commensurately increasing.
Popular Now
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles